Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
General Information
Revision date
2017-08-03
Product name
Mylotarg
Product Synonyms
Gemtuzumab Ozogamicin for Injection
Chemical name
Not determined
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360FD, H373
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
2.1 Classification of the substance or mixture
Germ Cell Mutagenicity: Category 2 Reproductive Toxicity: Category 1B Specific target organ systemic toxicity (repeated exposure): Category 2
Signal word
Danger
Hazard statements
H341 - Suspected of causing genetic defects H373 - May cause damage to organs through prolonged or repeated exposure H360FD - May damage fertility. May damage the unborn child.
Precautionary statements
P201 - Obtain special instructions before use P260 - Do not breathe dust/fume/gas/mist/vapors/spray P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up
2.3 Other hazards
An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
